Protocol Ledger

NCT07282665 · Phase III · RECRUITING

A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older

Interventional Phase III clinical trial protocol NCT07282665 sponsored by Pfizer in Infectious Disease and Vaccines, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2025-12-10 Enrollment: 32,500 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07282665
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)32,500 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)2 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07282665
Protocol FieldVerified Registry Value
NCT IdentifierNCT07282665
Consolidated Lead SponsorPfizer
Therapeutic Condition CohortInfectious Disease and Vaccines
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment32,500 participants (ESTIMATED)
Registered Start Date2025-12-10
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT07282665
Hospital Research SiteLocationSite Profile
Kaiser Permanente Los Angeles Medical CenterLos Angeles, CAOpen Hospital Dossier ->
Kaiser Permanente-OaklandOakland, CAOpen Hospital Dossier ->

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Pfizer across sibling Meru public-data platforms.

Search related sites and sponsors in the Interactive Directory, explore Infectious Disease and Vaccines Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI